Lupin gets eight observations from USFDA for Aurangabad plant

10 May 2017 Evaluate

US Food and Drug Administration (FDA) has issued eight observations for Lupin’s Aurangabad unit, which was inspected between April 17 and 26, 2017. These observations pertain to some market complaints regarding contamination of the drug & its effect on the consumer, some data related issues and some manufacturing protocols not being followed.

Lupin is a pharmaceutical company and is engaged in formulation of drugs and active pharmaceutical ingredients (APIs), generics, biotechnology, novel drug discovery and development, drug delivery systems and specialty pharmaceuticals.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×